Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion.
Thomas, S R
Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion. [electronic resource] - Lancet (London, England) Mar 1999 - 984-5 p. digital
Publication Type: Letter
0140-6736
10.1016/S0140-6736(98)05447-6 doi
Adenosine Triphosphate--pharmacology
Adult
Amiloride--pharmacology
Bronchodilator Agents--pharmacology
Chloride Channels--drug effects
Chlorides--metabolism
Cystic Fibrosis--genetics
Cystic Fibrosis Transmembrane Conductance Regulator--genetics
Diuretics--pharmacology
Female
Forced Expiratory Volume--drug effects
Homozygote
Humans
Isoproterenol--pharmacology
Male
Membrane Potentials--drug effects
Mutation--genetics
Retrospective Studies
Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion. [electronic resource] - Lancet (London, England) Mar 1999 - 984-5 p. digital
Publication Type: Letter
0140-6736
10.1016/S0140-6736(98)05447-6 doi
Adenosine Triphosphate--pharmacology
Adult
Amiloride--pharmacology
Bronchodilator Agents--pharmacology
Chloride Channels--drug effects
Chlorides--metabolism
Cystic Fibrosis--genetics
Cystic Fibrosis Transmembrane Conductance Regulator--genetics
Diuretics--pharmacology
Female
Forced Expiratory Volume--drug effects
Homozygote
Humans
Isoproterenol--pharmacology
Male
Membrane Potentials--drug effects
Mutation--genetics
Retrospective Studies